Sessa Capital’s MacroGenics MGNX Stock Holding History

Sessa Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-244,864	Closed	-$1.76M	–	31
2023 Q1	$1.76M	Hold	244,864	–	–	0.07%	37
2022 Q4	$1.64M	Hold	244,864	–	–	0.1%	31
2022 Q3	$847K	Hold	244,864	–	–	0.06%	30
2022 Q2	$722K	Hold	244,864	–	–	0.04%	32
2022 Q1	$2.16M	Buy	+244,864	New	+$2.7M	0.1%	41

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sessa Capital's MGNX Position: Q2 2023 in Review

Sessa Capital sold out of MacroGenics (MGNX) in Q2 2023, closing a stake of 244,864 shares — an estimated $1.76M sold.

Sessa Capital first reported a position in MGNX in Q1 2022 and held it in 5 quarters. The position peaked at $2.16M in Q1 2022. 131 funds tracked by Wall St. Rank hold MGNX as of Q2 2023.

Sessa Capital reported no remaining MacroGenics position as of Q2 2023 after selling out during the quarter.
Sessa Capital sold 244,864 MacroGenics shares in Q2 2023, an estimated $1.76M.
Sessa Capital first reported a position in MacroGenics in Q1 2022 and held it in 5 quarters.
Sessa Capital's MacroGenics position peaked at $2.16M in Q1 2022.
131 funds tracked by Wall St. Rank held MacroGenics as of Q2 2023.

Based on Sessa Capital's 13F filing for Q2 2023, filed 14 Aug 2023.